Synlogic Secures $5 Million Investment In Series A Funding Round

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Synlogic, Inc., a biotechnology company focused on the development of therapeutic microbes, today announced the Bill & Melinda Gates Foundation has joined Atlas Venture and New Enterprise Associates (NEA) in the previously announced Series A funding round of the company, providing validation of the broad potential of novel engineered bacteria for therapeutic use. Along with developing its technology platform and proprietary therapeutic applications, Synlogic will collaborate with the Gates Foundation on applications relevant to the developing world.

Help employers find you! Check out all the jobs and post your resume.

Back to news